Literature DB >> 9627174

Reduced TNFalpha and IL-6 production in patients who mount a preoperative acute phase response.

W Haupt1, H Zirngibl, P Klein, J Riese, W Hohenberger.   

Abstract

BACKGROUND/AIMS: In some patients postoperative infective complications are related to a reduced resistance to the operative trauma and the perioperative microbiological challenge. To investigate preoperative alterations in the immune responses in patients who had mounted an acute-phase response before the operation, we measured the capacity of tumor necrosis factor alpha and interleukin-6 production in whole blood. PATIENTS/
METHODS: Serum concentrations of C-reactive protein, alpha1-antitrypsin, albumin, and prealbumin were measured in 89 patients submitted for major abdominal surgery on their admission to hospital.
RESULTS: In 23 patients (26%) we found concentrations of at least one, and in 16 patients (18%) of two or more of these variables beyond the reference range. Patients who mounted an acute-phase response released 37% less TNFalpha (1339 vs. 848 pg/ml) and 31% less IL-6 (24293 vs. 16900 pg/ml) when whole blood was stimulated with lipopolysaccharide 0.5 microg/ml.
CONCLUSION: Patients who mount an acute-phase response before operation may thus have a downregulated immune response at the level of proinflammatory cytokines. This is likely to alter their resistance to invasive micro-organisms in the perioperative period.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627174     DOI: 10.1007/s004230050094

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  2 in total

Review 1.  [Relaparotomy in secondary peritonitis Planned relaparotomy or relaparotomy on demand?].

Authors:  B Lamme; C W Mahler; J W O van Till; O van Ruler; D J Gouma; M A Boermeester
Journal:  Chirurg       Date:  2005-09       Impact factor: 0.955

2.  The acute-phase response impairs host defence against Enterococcus faecium peritonitis.

Authors:  Masja Leendertse; Rob J L Willems; Ida A J Giebelen; Petra S van den Pangaart; Marc J M Bonten; Tom van der Poll
Journal:  Immunology       Date:  2008-10-30       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.